Ali Pay Intelligent Navigation Applet-aided Pre-hospital Triage for Non-emergency Medical Service Patients With Acute Ischemic Stroke

Recruiting N/A Interventional Study
Acute Ischemic Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
20,000 (estimated)
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
According to the Bigdata Observatory platform for Stroke of China (BOSC), the proportion of patients with acute ischemic stroke (AIS) receiving intravenous thrombolysis or endovascular treatment in China is 5.64% and 1.45% respectively. One of the important reasons for the low treatment rate is the prolonged pre-hospital and in-hospital delay. Besides, for patients receiving reperfusion therapy, t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients diagnosed as acute ischemic stroke undergoing reperfusion therapy within 24 hours of onset Exclusion Criteria: * Patients transported to hospitals via emergency medical service * Patients with in-hospital stroke
Contacts

Min Lou, PhD, MD

86057187783777

lm99@zju.edu.cn

CONTACT